Efficacy and Safety of Telmisartan/Rosuvastatin Co-administration in Hypertensive Patients With Hyperlipidemia

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 310 participants.

Also called NCT02087540

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 310 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02087540
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
Not reported
Countries
South Korea (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02087540. Randomized; quadruple masking; primary purpose treatment. Start 2013-05 (registry gives no type); primary completion 2014-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of Telmisartan/Rosuvastatin Co-administration in Hypertensive Patients With Hyperlipidemia
Condition
Hypertension
Condition
Hyperlipidemia
Intervention (Drug)
Telmisartan 80mg
Intervention (Drug)
Rosuvastatin 20mg
Intervention (Drug)
Rosuvastatin 10mg
Intervention (Drug)
Placebo(for Telmisartan 80mg)
Intervention (Drug)
Placebo(for Rosuvastatin 20mg)
Intervention (Drug)
Placebo(for Rosuvastatin 10mg)
Lead sponsor
IlDong Pharmaceutical Co Ltd (class: industry)

Record details

Record id
cardio:ct-nct02087540
Content hash
ced2bc7dcdfda329fc4fac1014a34ea1d00d491bf0c6c679976a247b2320cb56